142 related articles for article (PubMed ID: 23149328)
1. Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis.
Miyata Y; Ohba K; Matsuo T; Watanabe S; Hayashi T; Sakai H; Kanetake H
Urology; 2013 Jan; 81(1):136-42. PubMed ID: 23149328
[TBL] [Abstract][Full Text] [Related]
2. Relationship between prostaglandin E2 receptors and clinicopathologic features in human prostate cancer tissue.
Miyata Y; Kanda S; Maruta S; Matsuo T; Sakai H; Hayashi T; Kanetake H
Urology; 2006 Dec; 68(6):1360-5. PubMed ID: 17169665
[TBL] [Abstract][Full Text] [Related]
3. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
[TBL] [Abstract][Full Text] [Related]
4. Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancer.
Huang HF; Shu P; Murphy TF; Aisner S; Fitzhugh VA; Jordan ML
Mol Cancer Res; 2013 Apr; 11(4):427-39. PubMed ID: 23364535
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer.
Matsumoto K; Nakayama Y; Inoue Y; Minagawa N; Katsuki T; Shibao K; Tsurudome Y; Hirata K; Nagata N; Itoh H
Dis Colon Rectum; 2007 Mar; 50(3):308-14. PubMed ID: 17164964
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
7. Pathological significance and predictive value for biochemical recurrence of c-Fes expression in prostate cancer.
Miyata Y; Watanabe S; Matsuo T; Hayashi T; Sakai H; Xuan JW; Greer PA; Kanda S
Prostate; 2012 Feb; 72(2):201-8. PubMed ID: 21563194
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer.
Rodríguez-Berriguete G; Sánchez-Espiridión B; Cansino JR; Olmedilla G; Martínez-Onsurbe P; Sánchez-Chapado M; Paniagua R; Fraile B; Royuela M
Cytokine; 2013 Nov; 64(2):555-63. PubMed ID: 24063999
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma.
Thelen A; Scholz A; Weichert W; Wiedenmann B; Neuhaus P; Gessner R; Benckert C; Jonas S
Am J Gastroenterol; 2010 May; 105(5):1123-32. PubMed ID: 19997097
[TBL] [Abstract][Full Text] [Related]
10. EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality.
Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Wang W; Lönnroth C; Lundholm K
Int J Cancer; 2007 Jul; 121(2):232-40. PubMed ID: 17290397
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
[TBL] [Abstract][Full Text] [Related]
12. Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis.
Kubo H; Hosono K; Suzuki T; Ogawa Y; Kato H; Kamata H; Ito Y; Amano H; Kato T; Sakagami H; Hayashi I; Sugimoto Y; Narumiya S; Watanabe M; Majima M
Biomed Pharmacother; 2010 Feb; 64(2):101-6. PubMed ID: 20034758
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells.
Ueta M; Matsuoka T; Sotozono C; Kinoshita S
Cornea; 2012 Nov; 31(11):1294-8. PubMed ID: 22475642
[TBL] [Abstract][Full Text] [Related]
14. Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012).
Flesch D; Merk D; Lamers C; Schubert-Zsilavecz M
Expert Opin Ther Pat; 2013 Feb; 23(2):233-67. PubMed ID: 23289354
[TBL] [Abstract][Full Text] [Related]
15. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma.
Coşkun U; Akyürek N; Dursun A; Yamaç D
J Surg Res; 2010 Nov; 164(1):110-5. PubMed ID: 19628230
[TBL] [Abstract][Full Text] [Related]
16. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
17. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer.
Ishida E; Nakamura M; Shimada K; Tasaki M; Konishi N
Pathobiology; 2009; 76(1):30-8. PubMed ID: 19188748
[TBL] [Abstract][Full Text] [Related]
19. Prognostic markers in clinically localized prostate cancer.
Pettaway CA
Tech Urol; 1998 Mar; 4(1):35-42. PubMed ID: 9568775
[TBL] [Abstract][Full Text] [Related]
20. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy.
Henshall SM; Horvath LG; Quinn DI; Eggleton SA; Grygiel JJ; Stricker PD; Biankin AV; Kench JG; Sutherland RL
J Natl Cancer Inst; 2006 Oct; 98(19):1420-4. PubMed ID: 17018789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]